维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Helfrich BA"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Baseline gene expression predicts sensitivity to gefitinib in nonsmall cell lung cancer cell lines 显示文摘	Coldren CD Helfrich BA Witta SE	2006	Mol Cancer Res2006，4，8：	1
2	Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma显示文摘	Frederick BA Helfrich BA Coldren CD		0，，：	1
3	ZD1839,a selective epidermal growth factor receptor tyrosine kinase inhibitor alone and in combination with radiation and Chemstherapy as a new therapeutic strategy in non-small-cell lung cancer显示文摘	Raben D Helfrich BA Chan D	2002	Semin-Oncol2002，29，4：	1
4	Epithelial to mes- enchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma显示文摘	Frederick BA Helfrich BA Coldren CD	2007	Mol Cancer Ther2007，6，6：	1
5	Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines显示文摘	Coldren CD Helfrich BA Witta SE	2006	Mol Cancer Res2006，4，8：	1
6	ZD1839,a selective epidermal growth factor receptor tyrosine kinase inhibitor,alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer显示文摘	Raben D Helfrich BA Chan D	2002	Semin Oncol2002，29，14：	1
7	Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines显示文摘	Coldren CD Helfrich BA Witta SE	2006	Mol Cancer Res2006，4，8：	1
8	ZD1839,a selective epidermal growth factor receptor tyrosine kinase inhibitor,alone and in combination with radiation and chemoterapy sa a new therapeutic strategy in non-small cell lung cancer显示文摘	Raben D Helfrich BA Chan D	2002	Semin Oncol2002，29，：	1
9	Baseline gene expression predicts sensitivity to gefitinib in non- small cell lung cancer cell lines 显示文摘	Coldren CD Helfrich BA Witta SE et al	2006	Mol Cancer Res2006，4，8：	1
10	Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines 显示文摘	Coldren CD Helfrich BA Witta SE	2006	Mol Cancer Res2006，4，：	1
11	Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines显示文摘	Coldren CD Helfrich BA Witta SE		0，，08：	1
12	Antitumor activity of the epidermal growth factor receptor ( EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa)in non - small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels 显示文摘	Helfrich BA Raben D VareUa - Garcia M	2006	Clin Cancer Res2006，12，23：	1
13	Baseline geneexpression predicts sensitivity to gefitinib in nonsmall celllung cancer cell lines显示文摘	Coldren CD Helfrich BA Witta SE	2006	Mol Cancer Res2006，4，8：	1
14	Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, lressa) in non - small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels 显示文摘	Helfrich BA Raben D Varella - Garcia M	2006	Clin Cancer Res2006，12，23：	1
15	Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma 显示文摘	Frederick BA Helfrich BA Coldren CD	2007	Mol Cancer Ther2007，6，6：	1
16	Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839,Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels显示文摘	Helfrich BA Raben D Varella-Garcia M	2006	Clin Cancer Res2006，12，23：	1
17	Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcino- ma 显示文摘	Frederick BA Helfrich BA Coldren CD	2007	Mol Cancer Ther2007，6，6：	1
18	Epithe- lial to mesenchymal transition predicts gefitinib resistan- ce in cell lines of head and neck squamous cell carci- noma and non-small cell lung carcinoma显示文摘	Frederick BA Helfrich BA Coldren CD	2007	Mol Cancer Ther2007，6，6：	1
19	Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma显示文摘	Frederick BA Helfrich BA Coldren CD	2007	Mol Cancer Ther2007，6，6：	1
20	Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines显示文摘	Coldren CD Helfrich BA Witta SE	2006	Mol CancerRes2006，4，8：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示